Stone Pharmaceutical Group: profit attributable to shareholders in the first quarter was 1.429 billion yuan, up 1.7% from the same period last year.

[stone Pharmaceutical Group: 1.429 billion yuan profit attributable to shareholders in the first quarter increased 1.7 percent year on year] on May 25, Stone Pharmaceutical Group announced on the Hong Kong Stock Exchange on the 25th that the company's first-quarter earnings were 8.053 billion yuan, an increase of 2.3 percent over the same period in 2022. The profit attributable to shareholders was 1.429 billion yuan, an increase of 1.7% over the same period in 2022. Excluding the fair value loss of financial assets at fair value included in profit or loss and share-based honorarium expenses, the basic profit attributable to shareholders is 1.545 billion yuan, an increase of 0.1% over the same period in 2022.